The experiments reported here illustrate a few of the factors apart from genes which can influence hormone-responsive generation of cyclic adenosine 3':5'-monophosphate in human fibroblasts. For both normal and cystic fibrosis fibroblasts, the isoproterenol stimulation ratio was maximal 2 to 3 days after subculture and declined thereafter; prostaglandin E1 stimulation ratio was maximal 7 to 10 days after subculture. Cells dislodged from the plate by either scraping or typsinization had reduced isoproterenol or prostaglandin E1 stimulation ratios compared to cells studied in situ. Fibroblasts from healthy controls and cystic fibrosis patients plated simultaneously and grown in three different culture conditions responded similarly to the change in growth conditions. Addition to the incubation medium of polyamines, calcium, magnesium, or guanosine triphosphate did not alter the stimulation ratios for isoproterenol or prostglandin E1. Repeated measures analysis indicates that cellular content of cyclic adenosine 3':5'-monophosphate is not a reliable measure for comparing cell lines; isoproterenol stimulation ratio is a reliable measure, but there is large variation from cell line to cell line. Isoproterenol stimulation ratio was the same for normal and cystic fibrosis fibroblasts in each of the three culture conditions tested at both three and ten days after subculture.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1203/00006450-198007000-00004 | DOI Listing |
Because of the lengthening of their life-expectancy, more people with cystic fibrosis (CF) now pursue parenthood. To explore the experience of parenting while having CF, 18 French parents with CF were interviewed (including 12 mothers and 9 participants with a lung transplant). A thematic analysis of the interview transcripts was conducted.
View Article and Find Full Text PDFJ Clin Transl Endocrinol
December 2024
Division of Endocrinology Diabetes and Metabolism, Department of Medicine, University of Minnesota, Minneapolis, MN, USA.
Cystic fibrosis-related diabetes (CFRD) is the most common non-pulmonary comorbidity in people with cystic fibrosis (CF). Current guidelines recommend insulin therapy as the treatment of choice for people with CFRD. In the past, obesity and overweight were uncommon in individuals with CF.
View Article and Find Full Text PDFRespir Med Case Rep
November 2024
Infectious and Tropical Diseases Unit, Careggi University Hospital, Florence, Italy.
Cystic fibrosis (CF)-related central (CNS) and peripheral nervous system (PNS) disorders have not yet been fully described. We report the first case of post-infective neuromuscular hyperexcitability syndrome in a 23-year-old male patient with CF and pulmonary exacerbation. CNS radiological investigations were unremarkable and no autoantibodies were detected.
View Article and Find Full Text PDFLung
January 2025
Mother and Child Department, Cystic Fibrosis Center, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
Purpose: The study evaluated the effects of elexacaftor/tezacaftor/ivacaftor (ETI) therapy in people with cystic fibrosis (pwCF) and a clinical history of Aspergillus fumigatus (AF) infection.
Methods: This prospective cohort study included pwCF who initiated ETI therapy and had received antifungal treatment in the preceding five years due to allergic bronchopulmonary aspergillosis (ABPA group) or other AF-related clinical manifestations (AF group). A control group of pwCF with no prior respiratory cultures positive for AF was also included.
Epidemiology
December 2024
Department of Public Health, Policy and Systems, University of Liverpool, Liverpool, UK.
Background: Children with cystic fibrosis (CF) from socioeconomically deprived areas have poorer growth, worse lung function, and shorter life expectancy than their less-deprived peers. While early growth is associated with lung function around age 6, it is unclear whether improving early growth in the most deprived children reduces inequalities in lung function.
Methods: We used data from the UK CF Registry, tracking children born 2000-2010 up to 2016.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!